Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 4851-4900 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT06057753
MyStroke in Chronic Stroke
NAActive, not recruiting
100 participants
Started: Oct 17, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06002503
Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection
PHASE1Active, not recruiting
46 participants
Started: Oct 16, 2023 · Completed: May 31, 2025
1 condition2 sponsors1 location
NCT05828082
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
PHASE2Active, not recruiting
20 participants
Started: Oct 16, 2023 · Completed: Jun 18, 2026
4 conditions1 sponsor26 locations
NCT06372002
Effectiveness and Cost-Effectiveness of Cognitive Stimulation Therapy - Spain (CST-ES) in People Living With Dementia
NAActive, not recruiting
683 participants
Started: Oct 16, 2023 · Completed: Jul 31, 2024
3 conditions3 sponsors46 locations
NCT06006702
A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants
PHASE1Active, not recruiting
60 participants
Started: Oct 16, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05945485
A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults
PHASE1Active, not recruiting
10 participants
Started: Oct 16, 2023 · Completed: May 26, 2026
1 condition1 sponsor1 location
NCT06091267
PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes
PHASE1/PHASE2Active, not recruiting
72 participants
Started: Oct 16, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06141564
Detect and Expunge Concealed Tumors of the Liver
N/AActive, not recruiting
360 participants
Started: Oct 16, 2023 · Completed: Aug 1, 2026
1 condition2 sponsors1 location
NCT06045806
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
PHASE3Active, not recruiting
618 participants
Started: Oct 16, 2023 · Completed: Aug 11, 2025
1 condition3 sponsors101 locations
NCT06092970
An Evaluation of Patient Reported Outcomes and Clinical Outcomes
N/AActive, not recruiting
379 participants
Started: Oct 16, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor39 locations
NCT05710757
Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening
NAActive, not recruiting
60 participants
Started: Oct 16, 2023 · Completed: Sep 30, 2024
2 conditions1 sponsor1 location
NCT05797441
Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy
NAActive, not recruiting
80 participants
Started: Oct 16, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor8 locations
NCT06102005
Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma
PHASE2Active, not recruiting
685 participants
Started: Oct 16, 2023 · Completed: Mar 23, 2026
1 condition1 sponsor156 locations
NCT05423652
Aiding COPD and CHF Ultrasound-guided Management Through ENhanced Point Of Care UltraSound
NAActive, not recruiting
20 participants
Started: Oct 16, 2023 · Completed: Sep 30, 2025
3 conditions4 sponsors1 location
NCT05612074
Methemoglobin Concentration in High Dose Inhaled Nitric Oxide
EARLY_PHASE1Active, not recruiting
10 participants
Started: Oct 16, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06034028
J-Valve TF Early Feasibility Study
NAActive, not recruiting
25 participants
Started: Oct 16, 2023 · Completed: Aug 25, 2029
3 conditions1 sponsor9 locations
NCT06075667
A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
PHASE3Active, not recruiting
150 participants
Started: Oct 16, 2023 · Completed: Jul 31, 2029
2 conditions1 sponsor33 locations
NCT06015633
Ocular, Vascular, and Genetic Findings in AMD Patients
N/AActive, not recruiting
50 participants
Started: Oct 15, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05500690
Understanding Effects of Folic Acid on the Methylosome and Transcriptome of Women With Spina Bifida Affected Pregnancies
NAActive, not recruiting
69 participants
Started: Oct 15, 2023 · Completed: Nov 30, 2025
2 conditions2 sponsors1 location
NCT06637969
Mindfulness-based Interventions on Psychophysiological Recovery and Physical Functioning After Coronary Heart Surgery
NAActive, not recruiting
64 participants
Started: Oct 15, 2023 · Completed: Dec 30, 2025
4 conditions1 sponsor1 location
NCT05736562
Use of Ritual Epost Postnatal Multivitamins During the Postpartum Period
NAActive, not recruiting
70 participants
Started: Oct 15, 2023 · Completed: Nov 30, 2025
2 conditions2 sponsors2 locations
NCT06125379
Brief Mindfulness-based Intervention for Indonesian Teacher in Rural Area
NAActive, not recruiting
80 participants
Started: Oct 15, 2023 · Completed: Jun 25, 2025
1 condition2 sponsors1 location
NCT06169787
Sentinel Lymph Nodes Biopsy in Cervical Cancer
N/AActive, not recruiting
70 participants
Started: Oct 14, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06160024
Data Quality of National Quality Indicators in Long-term Care Facilities: a Validation and Evaluation Study
NAActive, not recruiting
30 participants
Started: Oct 14, 2023 · Completed: May 31, 2026
1 condition3 sponsors3 locations
NCT05854498
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
PHASE2Active, not recruiting
25 participants
Started: Oct 13, 2023 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT06084390
Interdisciplinary Rehabilitation for Chronic Pain in Primary Healthcare
NAActive, not recruiting
200 participants
Started: Oct 13, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06000683
Empowering Patients' Lung Cancer Screening Uptake
NAActive, not recruiting
70 participants
Started: Oct 13, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT06045611
The Effect of Oral Intake of Animal and Plant Proteins on the Metabolism in Healthy Women
NAActive, not recruiting
28 participants
Started: Oct 13, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
PHASE1Active, not recruiting
40 participants
Started: Oct 13, 2023 · Completed: Mar 31, 2026
12 conditions1 sponsor15 locations
NCT06120842
Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution
PHASE1/PHASE2Active, not recruiting
201 participants
Started: Oct 13, 2023 · Completed: Nov 30, 2027
3 conditions1 sponsor1 location
NCT06289283
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder
N/AActive, not recruiting
38 participants
Started: Oct 12, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05961956
Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
PHASE1/PHASE2Active, not recruiting
5 participants
Started: Oct 12, 2023 · Completed: Nov 15, 2025
1 condition3 sponsors1 location
NCT05931432
A Tailored and Digital Approach to Address Equity and Support Well-being for Healthcare Workers in the Era of COVID
NAActive, not recruiting
293 participants
Started: Oct 12, 2023 · Completed: Mar 1, 2026
3 conditions2 sponsors1 location
NCT06095102
A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)
PHASE3Active, not recruiting
311 participants
Started: Oct 12, 2023 · Completed: Jun 10, 2027
1 condition1 sponsor90 locations
NCT06095115
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
PHASE3Active, not recruiting
684 participants
Started: Oct 12, 2023 · Completed: Apr 6, 2027
1 condition1 sponsor170 locations
NCT06043310
Estrogen and Microvascular Function
N/AActive, not recruiting
45 participants
Started: Oct 12, 2023 · Completed: Dec 31, 2031
4 conditions1 sponsor1 location
NCT06028984
Self-guided Treatment for Depression
NAActive, not recruiting
248 participants
Started: Oct 12, 2023 · Completed: Sep 30, 2025
1 condition3 sponsors1 location
NCT06109649
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
PHASE3Active, not recruiting
200 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor30 locations
NCT05961098
A Study of RBD1016 in CHB Participants
PHASE2Active, not recruiting
48 participants
Started: Oct 11, 2023 · Completed: Dec 15, 2025
1 condition1 sponsor4 locations
NCT05972525
What Matters to Patients With Severe Hip or Knee Osteoarthritis?
NAActive, not recruiting
615 participants
Started: Oct 11, 2023 · Completed: Jul 11, 2026
2 conditions2 sponsors3 locations
NCT05537220
Oral N-acetylcysteine for Retinitis Pigmentosa
PHASE3Active, not recruiting
483 participants
Started: Oct 11, 2023 · Completed: May 31, 2029
1 condition32 sponsors31 locations
NCT06052852
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
PHASE1Active, not recruiting
147 participants
Started: Oct 11, 2023 · Completed: Mar 31, 2028
7 conditions2 sponsors6 locations
NCT06733870
Peri-implant Soft Tissue and Bone Evaluation in Fully Computer Guided Immediate Implants
NAActive, not recruiting
16 participants
Started: Oct 11, 2023 · Completed: Dec 20, 2024
1 condition1 sponsor1 location
NCT04777851
Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7
PHASE3Active, not recruiting
496 participants
Started: Oct 11, 2023 · Completed: Feb 28, 2026
1 condition2 sponsors26 locations
NCT05934786
Rehabilitation of Cognition and Psychosocial Well-being in Epilepsy
NAActive, not recruiting
70 participants
Started: Oct 11, 2023 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT06128200
NEUROMARK Randomized Controlled Trial
NAActive, not recruiting
132 participants
Started: Oct 10, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor16 locations
NCT06099704
Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Dermatitis
N/AActive, not recruiting
305 participants
Started: Oct 10, 2023 · Completed: Apr 10, 2026
1 condition2 sponsors29 locations
NCT07111312
Clinical Evaluation of a Nutraceutical Supplement (Olistic Women) for Hair Growth and Hair Loss in Human Volunteers
NAActive, not recruiting
106 participants
Started: Oct 10, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor2 locations
NCT05377827
Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
PHASE1Active, not recruiting
6 participants
Started: Oct 10, 2023 · Completed: Apr 30, 2026
15 conditions2 sponsors1 location
NCT05881278
XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
NAActive, not recruiting
141 participants
Started: Oct 10, 2023 · Completed: Nov 30, 2029
2 conditions1 sponsor20 locations